XVIVO

mRNAs as Medicines 

Prev Next
Previous

The Role of PKR Activation in Sickle Cell Disease

Next medical animation of XVIVO and Korro Bio continued their partnership to create an animation for Korro’s RNA editing oligonucleotide candidate for alpha-1 antitrypsin deficiency (AATD) from their proprietary OPERA™ platform. The purpose of the animation was to illustrate the unmet need for AATD patients, the role of the protein AAT in the disease, and the promise of Korro’s RNA editing candidate.

Alpha-1 Antitrypsin Deficiency (AATD) Animation

Moderna was creating a curriculum to inspire and educate learners about the opportunity mRNA presents as a medicine. The objective was to create an engaging online lecture that would serve both internal company training and public education. For XVIVO, it involved producing over 30 minutes of high-quality 3D animation focusing on mRNA technology, molecular and cellular processes, and therapeutic advancements.

Keywords: Animation, 3D, Video, Education, Patient Education, Technology, Professional Education, Biotechnology, Molecular Biology, Virology

XVIVO